Induction chemotherapy for locoregionally advanced head and neck cancer
: Past, present, future?
Radiotherapeutic management of locally advanced head and neck cancer
. Expert Rev Anticancer Ther.
Impact of chemotherapy with concurrent radiotherapy on quality of life in post-operative advanced head and neck cancer
patients: A cross-sectional study.
Evaluation of chemotherapy response in patients with advanced head and neck cancer
using [F-18] fluorodeoxyglucose positron emission tomography.
Alterations in taste is a temporary side effect for most patients being treated for advanced head and neck cancer
. Taste buds are located on the tongue, palate, tonsil, and nasopharynx.
The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer
: prognostic factors.
The impact of nutritional status on the prognoses of patients with advanced head and neck cancer
. Cancer 1999; 86: 519-27.
(2,4,11) Preoperative permanent balloon occlusion of an internal carotid artery in patients with advanced head and neck cancer
has been described for those with impending CBS.
Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
. N Engl J Med 1998;338:1798-804.
Planned postradiotherapy neck dissection in patients with advanced head and neck cancer
. Head Neck.
In the past few years, chemotherapy delivered concomitantly with altered fractionation radiotherapy has been investigated in patients with advanced head and neck cancer
. [61-63] Brizel et al at Duke University reported the results of a randomized trial wherein the outcome of twice-daily radiotherapy and concurrent 5-fluorouracil and cisplatin chemotherapy was superior to that of twice-daily radiotherapy alone.
Buntzel et al conducted a phase II study of 39 patients with advanced head and neck cancer
who received a combination of fractionated radiotherapy and simultaneous carboplatin chemotherapy (total dose: 60 Gy).